Life Science Big News Roundup: Lexaria Receives Cannabis R&D License; Harvest One Phase II Clinical Trials on Satipharm CBD GelPell® Published in Peer-Reviewed Medical Journal Life Science Investing
T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand Medical Device Investing
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock Pharmaceutical Investing
